Sign in
Active, not recruitingNo phase

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm

Key facts

Who runs it
Jacobs institute
Where
Buffalo, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
10 people enrolled
Started
1 Sept 2023
Expected to end
30 Dec 2026
Type of study
Interventional
Treatments tested
  • Pipeline™ Flex Embolization Device with Shield Technology™
Record updated
10 March 2026

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments

Who cannot take part

  • Cannot provide consent or legally authorized representative not available to provide consent

Where in United States

  • University at Buffalo NeurosurgeryBuffalo, United States

About the trial

What the trial wants to find out

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

The group in the trial

  • Single arm studyTreatment being tested

    Occurrence of thromboembolic event(s)

    Treatment: Pipeline™ Flex Embolization Device with Shield Technology™

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
10 March 2026